Through the acquisition, BD — a medical equipment supplier — will expand its portfolio to include vascular, urology, oncology and surgical specialty products.
Both companies’ boards unanimously approved the agreement, and the deal is expected to close in fall 2017.
More articles on supply chain:
FDA finalizes decision to keep impounded execution drugs from Texas justice system
Sanofi epilepsy drug linked to birth deformities
Marathon 2nd drugmaker to resign from PhRMA this month
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.